An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease InternationalRoman‐Ulrich Müller, Ron T. Gansevoort, Émilie Cornec-Le Gall et al.|Nephrology Dialysis Transplantation|2021Cited by 135
An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease InternationalRoman‐Ulrich Müller, Stephen B. Walsh and Ron T. Gansevoort, A. Lianne Messchendorp et al.|KIDNEYS|2022Cited by 6